US equities |
GOOGL $283.82 ▼-12.64% GOOG $282.32 ▼-12.29% MU $934.27 ▼-4.98% MSFT $530.14 ▼-0.16% AMZN $243.79 ▼-4.25% META $624.52 ▲+1.96% NVDA $213.66 ▼-0.80% AAPL $348.91 ▲+1.48%
FinancialContent

Latest News about Roche Holding AG

Recent news which mentions Roche Holding AG

A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Zealand Pharma A/S AstraZeneca PLC Nestle SA
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Pfizer Inc Roche Holding AG Business News
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Roche Holding AG Pfizer Inc Social issues
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags Eli Lilly and Co Bristol/Myers Squibb Co Pharmaceuticals
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Pfizer Inc Roche Holding AG Merck & Co Inc
From CNBC.com News
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
Tags US: News Europe News Novartis AG
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Biotech and Pharmaceuticals Bristol/Myers Squibb Co Health & Science
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags GSK plc Novo Nordisk A/S AstraZeneca PLC
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Abbvie Inc Trade Business
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Mergers Amgen Inc LILLY DRN
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Abbvie Inc Johnson & Johnson Roche Holding AG
From CNBC.com News
Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
Tags Pharmaceuticals Business Trade
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Novo Nordisk A/S Health care industry Breaking News: Business
From CNBC.com News
Here are the top 15 companies for career growth in Singapore, according to LinkedIn
Tickers JOBS
Tags Make It / Careers Early career Changing jobs
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Bavarian Nordic A/S Trade Pharmaceuticals
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Companies Biotech and Pharmaceuticals LILLY DRN
From CNBC.com News
CNBC Daily Open: A muted inflation report for February supported markets even as the trade war heats up
Tags World Markets Intel Corp Daily Open
From CNBC.com News
Roche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidate
Tags Biotechnology Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Health care industry Novo Nordisk A/S Health & Science
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Health & Science Social issues Health care industry
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Tags Novartis AG Biotechnology Health & Science
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Health & Science Social issues Health care industry
From CNBC.com News
CNBC Daily Open: With all key data in, the Fed's policy path looks more uncertain
Tickers JOBS
Tags Interest Rates World Markets Technology
From CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
Tickers JOBS
Tags Interest Rates Technology World Markets
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Biotechnology Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
European stocks head for mixed open as selloff eases; U.S. inflation data due
Tags Stellantis NV Nestle SA LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Europe stocks set to open lower amid global downturn; earning season ramps up
Tags Nestle SA Stellantis NV LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Novo Nordisk A/S Breaking News: Markets Zealand Pharma A/S
From CNBC.com News
CNBC's Inside India newsletter: IPO boom looks to break new records
Tags BSE Ltd Roche Holding AG Asia: Business
From CNBC.com News
Roche alleges counterfeit diabetes medical devices were sold on Amazon
Tags Johnson & Johnson Crime Roche Holding AG
From CNBC.com News